quinidine has been researched along with encainide in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (65.12) | 18.7374 |
| 1990's | 8 (18.60) | 18.2507 |
| 2000's | 4 (9.30) | 29.6817 |
| 2010's | 3 (6.98) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Blair, IA; Funck-Brentano, C; Gray, HT; Pavlou, HN; Prakash, C; Roden, DM; Turgeon, J | 1 |
| Kadish, A; Morady, F; Toivonen, L | 1 |
| Anderson, JL | 1 |
| Funck-Brentano, C; Pavlou, HN; Roden, DM; Turgeon, J; Wong, W | 1 |
| Almotrefi, AA; Dzimiri, N | 1 |
| Arnsdorf, MF; Sawicki, GJ | 1 |
| Funck-Brentano, C; Roden, DM; Turgeon, J; Woosley, RL | 1 |
| Somberg, J | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Roy, D | 1 |
| Durkee, J; Hsu, PH; Lee, IK; Morganroth, J; Pool, PE; Salerno, DM; Somberg, JC | 1 |
| Echt, DS; Roden, DM; Woosley, RL | 1 |
| Morganroth, J; Nestico, PF | 2 |
| Morganroth, J | 1 |
| Kates, RE | 2 |
| Lampert, S; Lown, B; Podrid, PJ; Slater, W | 1 |
| Koskinen, PJ; Liisanantti, RK; Mäkynen, PJ; Saaristo, TE | 1 |
| Podrid, PJ | 1 |
| Atarashi, H; Hayakawa, H | 1 |
| Sanna, G | 1 |
| DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
| Prystowsky, EN | 1 |
| Somberg, JC | 1 |
| Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
| Roden, DM; Woosley, RL | 1 |
| Block, PJ; Winkle, RA | 1 |
| Harrison, DC; Mason, J; Sami, M; Winkle, R | 1 |
| DeBusk, RF; Harrison, DC; Houston, N; Kraemer, H; Sami, M; Shimasaki, C | 1 |
| Duff, HJ; Kronenberg, MW; Primm, RK; Roden, DM; Woosley, RL | 1 |
| Harrison, DC; Samuelsson, RG | 1 |
| Echt, DS; Griffin, JC; Keefe, DL; Mason, JW; Ross, DL; Swerdlow, CD; Sze, DY; Winkle, RA | 1 |
| Grey, E; Silverman, DI | 1 |
| Chow, MS; Fisher, JR; Kluger, J; Tisdale, JE | 1 |
13 review(s) available for quinidine and encainide
| Article | Year |
|---|---|
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials.
Topics: Administration, Oral; Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Encainide; Female; Heart Ventricles; Humans; Male; Middle Aged; Quinidine; Random Allocation; Time Factors | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Disopyramide; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Metabolites of cardiac antiarrhythmic drugs: their clinical role.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Disopyramide; Encainide; Humans; Lidocaine; Piperidines; Procainamide; Quinidine | 1984 |
6 trial(s) available for quinidine and encainide
| Article | Year |
|---|---|
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Effect of low dose quinidine on encainide pharmacokinetics and pharmacodynamics. Influence of genetic polymorphism.
Topics: Adult; Anilides; Biological Availability; Debrisoquin; Drug Interactions; Electrocardiography; Encainide; Humans; Male; Metabolic Clearance Rate; Middle Aged; Polymorphism, Genetic; Quinidine | 1989 |
Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Interactions; Electrocardiography; Encainide; Female; Humans; Male; Middle Aged; Quinidine; Random Allocation | 1986 |
Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials.
Topics: Administration, Oral; Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Encainide; Female; Heart Ventricles; Humans; Male; Middle Aged; Quinidine; Random Allocation; Time Factors | 1986 |
Comparison of encainide and quinidine for supraventricular tachyarrhythmias.
Topics: Administration, Oral; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Clinical Trials as Topic; Encainide; Female; Humans; Male; Middle Aged; Quinidine; Random Allocation; Recurrence; Tachycardia, Supraventricular | 1988 |
[Impressions and certainties concerning the harmful effects of anti-arrhythmic drugs].
Topics: Acetylation; Amiodarone; Anilides; Anti-Arrhythmia Agents; Clinical Trials as Topic; Encainide; Humans; Kinetics; Molecular Biology; Placebos; Procainamide; Quinidine | 1985 |
26 other study(ies) available for quinidine and encainide
| Article | Year |
|---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Drug Evaluation, Preclinical; Drug Interactions; Encainide; Phenotype; Purkinje Fibers; Quinidine; Stereoisomerism | 1991 |
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Encainide; Heart Conduction System; Humans; Mexiletine; Prospective Studies; Quinidine; Tachycardia | 1991 |
Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Dealkylation; Drug Interactions; Electrocardiography; Encainide; Female; Genetics; Humans; Male; Middle Aged; Phenotype; Quinidine | 1990 |
Effects of quinidine, lidocaine and encainide on guinea pig myocardial Na(+)-K(+)-ATPase activity.
Topics: Adenosine Triphosphate; Anilides; Animals; Encainide; Guinea Pigs; Heart; In Vitro Techniques; Lidocaine; Myocardium; Quinidine; Sodium-Potassium-Exchanging ATPase | 1990 |
Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Encainide; Heart Conduction System; In Vitro Techniques; Lidocaine; Moricizine; Phenothiazines; Purkinje Fibers; Quinidine; Sheep | 1989 |
Metabolites of antiarrhythmic drugs: are they clinically important?
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Procainamide; Quinidine | 1986 |
Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Retrospective Studies | 1988 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Importance of metabolites in antiarrhythmic therapy.
Topics: Acecainide; Agranulocytosis; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Procainamide; Propranolol; Quinidine | 1983 |
Encainide: a new and potent antiarrhythmic agent.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Bundle of His; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Encainide; Hemodynamics; Humans; Kinetics; Male; Purkinje Fibers; Quinidine; Recurrence | 1980 |
Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.
Topics: Adult; Ambulatory Care; Anilides; Anti-Arrhythmia Agents; Electrocardiography; Encainide; Exercise Test; Humans; Male; Middle Aged; Placebos; Quinidine; Tachycardia; Ventricular Fibrillation | 1981 |
Control of ventricular preexcitation and associated arrhythmias by encainide.
Topics: Anilides; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Lidocaine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors | 1981 |
Electrophysiologic evaluation of encainide with use of monophasic action potential recording.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Blood Pressure; Bundle of His; Dogs; Electrocardiography; Encainide; Heart; Quinidine | 1981 |
Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Blood Pressure; Drug Therapy, Combination; Electrophysiology; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia; Tocainide | 1982 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Recurrence; Retrospective Studies | 1993 |
Efficacy of class 1C antiarrhythmic agents in patients with inducible ventricular tachycardia refractory to therapy with class 1A antiarrhythmic drugs.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Benzeneacetamides; Electric Stimulation; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Piperidines; Quinidine; Retrospective Studies; Stroke Volume; Tachycardia, Ventricular | 1993 |